News | January 17, 2024
Agilent announces new ProteoAnalyzer system
Automated parallel capillary electrophoresis system simplifies protein analysis
Automated parallel capillary electrophoresis system simplifies protein analysis
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
Atlas AI combines NVIDIA BioNeMo cloud APIs for intelligent chemical and protein design
Arco Lab now holds a 50% stake in Neviton
Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
The congress aims at emphasizing on the most recent trends, advancements in the field of Obstetrics & Gynaecology
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
AMI to become part of Enpro’s Sealing Technologies Segment
Vyleesi is the first and only as-needed treatment approved by the Food and Drug Administration (FDA) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)
Subscribe To Our Newsletter & Stay Updated
